MedTrace Logo

Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity

NCT00880646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2009-10-29

No results posted yet for this study

Summary

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on body mass index, body fat mass, abdominal circumference, visceral fat mass, and serum biochemical parameters in overweight subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Oolong tea containing L-arabinose and indigestible dextrin

DIETARY_SUPPLEMENT

Oolong tea (Placebo)

Sponsors & Collaborators

  • Unitika Ltd.

    collaborator INDUSTRY

  • Hiroshima University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Completion
2009-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00880646 on ClinicalTrials.gov